These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 23555679)

  • 21. Histone chaperone HIRA, promyelocytic leukemia protein, and p62/SQSTM1 coordinate to regulate inflammation during cell senescence.
    Dasgupta N; Lei X; Shi CH; Arnold R; Teneche MG; Miller KN; Rajesh A; Davis A; Anschau V; Campos AR; Gilson R; Havas A; Yin S; Chua ZM; Liu T; Proulx J; Alcaraz M; Rather MI; Baeza J; Schultz DC; Yip KY; Berger SL; Adams PD
    Mol Cell; 2024 Sep; 84(17):3271-3287.e8. PubMed ID: 39178863
    [TBL] [Abstract][Full Text] [Related]  

  • 22. E2FBP1 antagonizes the p16(INK4A)-Rb tumor suppressor machinery for growth suppression and cellular senescence by regulating promyelocytic leukemia protein stability.
    Fukuyo Y; Takahashi A; Hara E; Horikoshi N; Pandita TK; Nakajima T
    Int J Oral Sci; 2011 Oct; 3(4):200-8. PubMed ID: 22010578
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Microtubule-associated protein 1 light chain 3 interacts with and contributes to growth inhibiting effect of PML.
    He W; Hu CX; Hou JK; Fan L; Xu YW; Liu MH; Yan SY; Chen GQ; Huang Y
    PLoS One; 2014; 9(11):e113089. PubMed ID: 25419843
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mitogen-activated protein kinase extracellular signal-regulated kinase 2 phosphorylates and promotes Pin1 protein-dependent promyelocytic leukemia protein turnover.
    Lim JH; Liu Y; Reineke E; Kao HY
    J Biol Chem; 2011 Dec; 286(52):44403-11. PubMed ID: 22033920
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Translational control of PML contributes to TNFα-induced apoptosis of MCF7 breast cancer cells and decreased angiogenesis in HUVECs.
    Hsu KS; Guan BJ; Cheng X; Guan D; Lam M; Hatzoglou M; Kao HY
    Cell Death Differ; 2016 Mar; 23(3):469-83. PubMed ID: 26383972
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Viral disruption of promyelocytic leukemia (PML) nuclear bodies by hijacking host PML regulators.
    Frappier L
    Virulence; 2011; 2(1):58-62. PubMed ID: 21217204
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Promyelocytic leukaemia protein links DNA damage response and repair to hepatitis B virus-related hepatocarcinogenesis.
    Chung YL; Wu ML
    J Pathol; 2013 Aug; 230(4):377-87. PubMed ID: 23620081
    [TBL] [Abstract][Full Text] [Related]  

  • 28. B Cell Linker Protein (BLNK) Is a Selective Target of Repression by PAX5-PML Protein in the Differentiation Block That Leads to the Development of Acute Lymphoblastic Leukemia.
    Imoto N; Hayakawa F; Kurahashi S; Morishita T; Kojima Y; Yasuda T; Sugimoto K; Tsuzuki S; Naoe T; Kiyoi H
    J Biol Chem; 2016 Feb; 291(9):4723-31. PubMed ID: 26703467
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Loss of the promyelocytic leukemia protein in gastric cancer: implications for IP-10 expression and tumor-infiltrating lymphocytes.
    Kim HJ; Song DE; Lim SY; Lee SH; Kang JL; Lee SJ; Benveniste EN; Choi YH
    PLoS One; 2011; 6(10):e26264. PubMed ID: 22022583
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PML depletion disrupts normal mammary gland development and skews the composition of the mammary luminal cell progenitor pool.
    Li W; Ferguson BJ; Khaled WT; Tevendale M; Stingl J; Poli V; Rich T; Salomoni P; Watson CJ
    Proc Natl Acad Sci U S A; 2009 Mar; 106(12):4725-30. PubMed ID: 19261859
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PML is a key component for the differentiation of myeloid progenitor cells to macrophages.
    Khalfin-Rabinovich Y; Weinstein A; Levi BZ
    Int Immunol; 2011 Apr; 23(4):287-96. PubMed ID: 21427174
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Functional reorganization of promyelocytic leukemia nuclear bodies during BK virus infection.
    Jiang M; Entezami P; Gamez M; Stamminger T; Imperiale MJ
    mBio; 2011; 2(1):e00281-10. PubMed ID: 21304169
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modulation of the Zac1's transactivation and coactivation functions via PML and Daxx within distinct subcellular localizations.
    Ho CL; Huang YC; Tai CK; Liu ST; Wang JK; Wang WM; Huang SM
    Int J Biochem Cell Biol; 2010 Jun; 42(6):902-10. PubMed ID: 20097304
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulation of the PML tumor suppressor in drug-induced senescence of human normal and cancer cells by JAK/STAT-mediated signaling.
    Hubackova S; Novakova Z; Krejcikova K; Kosar M; Dobrovolna J; Duskova P; Hanzlikova H; Vancurova M; Barath P; Bartek J; Hodny Z
    Cell Cycle; 2010 Aug; 9(15):3085-99. PubMed ID: 20699642
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of nuclear bodies in apoptosis signalling.
    Krieghoff-Henning E; Hofmann TG
    Biochim Biophys Acta; 2008 Nov; 1783(11):2185-94. PubMed ID: 18680765
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SCP phosphatases suppress renal cell carcinoma by stabilizing PML and inhibiting mTOR/HIF signaling.
    Lin YC; Lu LT; Chen HY; Duan X; Lin X; Feng XH; Tang MJ; Chen RH
    Cancer Res; 2014 Dec; 74(23):6935-46. PubMed ID: 25293974
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The deubiquitinylation and localization of PTEN are regulated by a HAUSP-PML network.
    Song MS; Salmena L; Carracedo A; Egia A; Lo-Coco F; Teruya-Feldstein J; Pandolfi PP
    Nature; 2008 Oct; 455(7214):813-7. PubMed ID: 18716620
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PML inhibits HIF-1alpha translation and neoangiogenesis through repression of mTOR.
    Bernardi R; Guernah I; Jin D; Grisendi S; Alimonti A; Teruya-Feldstein J; Cordon-Cardo C; Simon MC; Rafii S; Pandolfi PP
    Nature; 2006 Aug; 442(7104):779-85. PubMed ID: 16915281
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of a tumour suppressor network opposing nuclear Akt function.
    Trotman LC; Alimonti A; Scaglioni PP; Koutcher JA; Cordon-Cardo C; Pandolfi PP
    Nature; 2006 May; 441(7092):523-7. PubMed ID: 16680151
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Promyelocytic leukemia activates Chk2 by mediating Chk2 autophosphorylation.
    Yang S; Jeong JH; Brown AL; Lee CH; Pandolfi PP; Chung JH; Kim MK
    J Biol Chem; 2006 Sep; 281(36):26645-54. PubMed ID: 16835227
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.